CUSIP 140755307COMTVRDQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
64 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Slate Path Capital LP | 704.1K | $3.03M | 0 | Held |
| 2 | Vanguard Group Inc | 424.8K | $1.83M | +5.7K | Added |
| 3 | Blackrock, Inc. | 391.0K | $1.68M | +61.1K | Added |
| 4 | American Financial Group Inc | 223.7K | $961.7K |
| +223.7K |
| New |
| 5 | Geode Capital Management, LLC | 157.1K | $675.8K | +9.2K | Added |
| 6 | State Street Corp | 115.5K | $496.7K | +52.6K | Added |
| 7 | Renaissance Technologies LLC | 104.5K | $449.4K | +74.3K | Added |
| 8 | Silvercrest Asset Management Group LLC | 101.0K | $434.4K | +78.7K | Added |
| 9 | Morgan Stanley | 84.5K | $363.2K | +80.7K | Added |
| 10 | Duncan Williams Asset Management, LLC | 80.8K | $311.8K | +80.8K | New |
See every fund holding Tvardi Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders